Keywords: Bayer, R&D spending, Research pipeline, Xarelto

Bayer says it has well-stocked product pipeline, spending more than $4 billion on R&D

Article | 09 December 2010

Print This

Germany’s Bayer Group (Bayer: DE) aims to invest its resources as a whole more consistently in growth and ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in